Longwoods Healthcare Services Radio

Artificial Intelligence (AI) can introduce clarity to the clinical journey for the most-challenging diseases and treatment pathways.  AI brings power to consume large disparate data sets and transform information into succinct, actionable insights with the power to identify opportunities to reduce avoidable costs, predict medical events, and, ultimately, improve patient care. But developing, implementing, and interpreting to drive actionable results can be challenging without the right data, the right process, and the right actions to be successful. This session will focus on approaches for clinical decision support and identifying opportunities to engage providers with actionable care gaps aligned to best-practice guidelines.

Featuring:

Gene therapy has emerged as an exciting innovation for Canadians with rare diseases. As more gene therapy treatments gain approval in Canada, there is promise for transforming and advancing healthcare, especially in areas of high unmet need. Access to those new therapies, however, remains challenging. Join us to discover the untapped potential of gene therapy in Canada as this panel of experts addresses the barriers to access and explores innovative solutions to overcome them, ensuring every Canadian who needs it can access gene therapy with timely, equitable, and effective delivery. 

Featuring:

Ontario healthcare landscape.

There was a time when Canadians could confidently claim theirs was the best health system in the world. Time to face reality – that is no longer true. The system faces major challenges, with access to care at the top of the list of concerns. Despite spending more on healthcare than most developed countries, we struggle to create enough capacity to meet the needs of a rapidly growing and aging population.

What can we do to break out of this chronic decline and bring back a sense of vibrancy and optimism to the healthcare enterprise? Brian and Michael will discuss current trends and new ideas with the potential to change the narrative and address the explosive growth in the seniors demographic that is already upon us. There is lots to be optimistic about, if you know where to look. We need to think differently to create a different dynamic.

Featuring:

Insights on the struggles of life limiting experiences and understanding end-of-life care for patients, care providers and medical professionals. Patients and their caregivers require physical and emotional care, especially as they enter the later stages of life. Failure to attend to personhood can be as subtle as being kept waiting for an appointment, as insidious as being required to wear a plastic hospital bracelet that tracks patients according to an institutional number or code, as jarring as being referred to as an aberrant body part - the proverbial "GI bleed in room two" or "breast tumor in room three." This conversation on Dignity in Care will describe what healthcare providers need to know about the humanity and tone of care; and how they can engage in these facets of care in a thoughtful and meaningful way that will satisfy their patients' needs to be seen and appreciated as "whole persons."

Featuring

After decades of research and innovation, cell and gene therapies (CGTs) are unlocking new ways to revolutionize medicine. Distinct from traditional pharmaceutical treatments, CGTs represent highly precise and innovative approaches that target the underlying causes of genetic and acquired diseases with the aim of treating, preventing and potentially curing disease.

Over the past few years, we’ve seen the positive impact that CGTs such as CAR T-cell therapy – a blood cancer treatment that modifies T cells to target and eliminate cancer cells – have had on Canadians. With thousands of CGTs in development to treat diseases from cancers to rare disorders to type 1 diabetes and chronic heart failure, the novelty and highly technical nature of these therapies create new opportunities for improved health outcomes for Canadians, but successful integration will require a new playbook from those who assess, deliver and receive care.

From regulation to health technology assessments, reimbursement and education, we must ensure that our health systems are prepared to integrate these new innovations so that Canadians have access to potentially life changing treatments.

This Longwoods Leadership Discussion is funded by The Cell and Gene Therapy Round Table, a group of Canadian pharmaceutical companies interested in policies related to cell and gene therapies.

Featuring:

Featuring:

Kimberley Hanson, Chief Executive Officer, HealthPartners

Dr. David M. Kaplan, Vice President, Quality, Ontario Health

Dr. Karen Cross, Chief Executive Officer, MIMOSA Diagnostics

Dr. Lorraine Lipscombe, Senior Scientist, Women's College Hospital Research Institute

Amir Naseri, Senior Director, Pharmacy Services Strategy & Innovation Shoppers Drug Mart

Moderator: Dr. Tamara Wallington, Chief Health Promotion and Environmental Health Officer, Public Health Ontario

Improving the Prevention, Management, and Treatment of Diabetes and Other Chronic Diseases in Ontario In Ontario, diabetes affects 1 in 3 people and contributes to 30% of strokes, 40% of heart attacks, 50% of kidney failure requiring dialysis, and 70% of all non-traumatic lower limb amputations. It is also a leading cause of blindness. The toll on patients and caregivers is significant as is the impact on the healthcare system and economy.

In November of 2020, Longwoods hosted an event Diabetes Care and Management for Ontario focusing on the need for more to be done to support people in Ontario living with diabetes. The following year, the Ministry of Health’s 2022/23 mandate to Ontario Health directed the agency to “work in partnership with the Ministry of Health to develop a chronic disease strategy addressing prevention, management and treatment, with an initial focus on diabetes.” This mandate was renewed in 2023/24 with an added emphasis to complete the development and proceed with implementation of the strategy.

In parallel to the commitment made by the Ontario government, in October 2022 the federal government tabled the Diabetes Framework, another important step in the journey to reduce the rising rates of the diabetes epidemic. We are now at a pivotal time with government commitments being made to reduce the rates of the disease and the unsustainable burden it places on our province, population, and health system.

Our panel of thought leaders and healthcare experts will reflect on the current state of diabetes in Ontario and the plan moving forward to develop and implementation a provincial strategy.

#diabetes #diabetescare #novonordisk #chronicdisease #healthcare #healthcanada #longwoods #diabetestreatment #diabetesmanagement #diabetesprevention

Leigh Chapman, Chief Nursing Officer, Health Canada with Tim Guest, CEO, Canadian Nurses Association and Carly Weeks, Health Reporter, The Globe and Mail discuss why Retention is critical to today’s health workforce challenges in the context of a global nursing shortage.

This title “You can’t recruit your way out of a crisis” follows the International Council of Nurses (ICN) Congress, co-hosted by the CNA in Montreal, July 2023. The issue of the global nursing shortage was brought to the forefront as one of the most prominent issues in today’s global health landscape.

In this talk, these nurse leaders will cover current issues, and strategic solutions for the future of nursing. With a focus on how we got here, and where we’re going, the discussion topics will include retention, ethical recruitment, and improving work environments for nurses. The speakers will also highlight their hopes for the future of nursing and Canada’s publicly funded healthcare system.

The Ontario Long Term Care Association represents 70% of Ontario's long-term care homes. 

In four years, the oldest of the baby boomers’ generation will turn 80. By 2040, Ontario’s population over that age will nearly double.

Listen to today's conversation with Donna Duncan, CEO for the Ontario Long Term Care Association as we discuss this issue and many more. 

Phyxable – a world-class virtual care provider – and its partners, Micron Digital and Wizcraft Design Build Inc., have been selected by the Canadian Space Agency (CSA) as one of five Canadian companies to contribute to its “Health Beyond Initiative” for 2023.

By initiating a leading role in deep-space healthcare innovation, Canada can position itself on the international stage as a pioneer in the delivery of remote healthcare and, thereby, in the development of resources and technologies that can be used in deep space and in remote or rural areas on Earth. Healthcare strategies and technologies developed to support crew members on deep-space missions could be used to empower healthcare providers serving those in remote regions. Considering the needs of healthcare delivery in deep space and remote regions are in many ways comparable, it can be expected that their solutions will likely overlap. The lessons learned from healthcare projects in deep space can be adapted to remote healthcare delivery for underserved populations. These healthcare innovations have the potential to be radically transformative for national healthcare delivery, lowering costs, and improving health outcomes for all.

More than 150 certified respiratory educators, respirologists, allergists, general practitioners/family physicians, nurses, pharmacists, and respiratory therapists from across the country participated in the first Canadian stakeholder consensus to lay out a path for high-quality respiratory care for Canadians. 

With health systems across the country experiencing challenges, Canadians are struggling to access respiratory care, impacting their ability to control their symptoms, adding more pressure on an already strained acute care system. The cost of asthma to the Canadian economy is expected to climb to $4.2 billion annually by 2030. 

Recommendations from the study present policy makers with a road map and best practices to improve the quality of care, resulting in improved outcomes, quality of life and patient experience for Canadians living with severe asthma and their caregivers. 

Concerted action from policy makers and health system leaders will ensure all Canadians living with asthma have access to the quality and timely care they need.

Featuring:

Moderator: Carly Weeks, Health Reporter, The Globe and Mail